Mindbeam Research Unveils AI-Designed Pain Drug Candidates
BOSTON, Massachusetts, USA, July 9, 2026 Mindbeam Research has unveiled a significant advance in AI-driven drug discovery, demonstrating how...
Advertisement
Santhera Expands AGAMREE Distribution Across Central Asia and Caucasus
PRATTELN, Switzerland, July 13, 2026 Santhera Pharmaceuticals announced the expansion of its exclusive distribution agreement with Biomedica, extending commercial...
Hemab Reports Positive HMB-002 Data
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, July 12, 2026 Hemab Therapeutics announced encouraging new clinical findings from its HMB-002 program...
Insilico Medicine and CMS Expand AI Collaboration for CNS Therapies
HONG KONG, China, July 12, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), and...
Cannabix Advances Multi-Drug Breath Testing
VANCOUVER, British Columbia, July 6, 2026 Cannabix Technologies announced the successful detection of cocaine and its primary metabolite, benzoylecgonine,...
Atsena Selects ATSN-401 for Stargardt Disease
DURHAM, N.C., July 9, 2026 Atsena Therapeutics announced the selection of ATSN-401 as its lead clinical candidate for the...
IN8bio Publishes Positive Phase 1 GBM Data
NEW YORK, July 9, 2026 IN8bio announced the publication of peer-reviewed Phase 1 clinical trial results for its investigational...
Century Therapeutics Showcases CNTY-813 at EASD
PHILADELPHIA, July 9, 2026 Century Therapeutics announced that its CNTY-813 preclinical research has been selected for oral presentations at...
Elevar Receives FDA Complete Response Letter
FORT LEE, N.J., July 10, 2026 Elevar Therapeutics announced that the U.S. Food and Drug Administration (FDA) has issued...
Jackson Laboratory Wins ARPA-H Funding for Rare CNS Diseases
BAR HARBOR, Maine, USA, July 9, 2026 The Jackson Laboratory (JAX), in collaboration with the Broad Institute and a...
Advertisement
